Antibodies against endogenous retroviruses
Immunological Reviews · 2024
DOI: 10.1111/imr.13378 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, 2024. Verfasst von Mihaela Chisca und 3 weiteren Autor:innen. Beteiligte Einrichtung: Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK. Hauptthemen laut MEDLINE: Endogenous Retroviruses, Antibodies, Viral, Retroviridae Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, European Research Council, Francis Crick Institute.
Abstract (Originalsprache)
The human genome harbors hundreds of thousands of integrations of ancient retroviruses, amassed over millions of years of evolution. To reduce further amplification in the genome, the host prevents transcription of these now endogenous retroviruses (ERVs) through epigenetic repression and, with evolutionary time, ERVs are incapacitated by accumulating mutations and deletions. However, several members of recently endogenized ERV groups still retain the capacity to produce viral RNA, retroviral proteins, and higher order structures, including virions. The retention of viral characteristics, combined with the reversible nature of epigenetic repression, particularly as seen in cancer, allow for immunologically unanticipated ERV expression, perceived by the adaptive immune system as a genuine retroviral infection, to which it has to respond. Accordingly, antibodies reactive with ERV antigens have been detected in diverse disorders and, occasionally, in healthy individuals. Although they are part of self, the retroviral legacy of ERV antigens, and association with and, possibly, causation of disease states may set them apart from typical self‐antigens. Consequently, the pathogenic or, indeed, host‐protective capacity of antibodies targeting ERV antigens is likely to be context‐dependent. Here, we review the immunogenicity of typical ERV proteins, with emphasis on the antibody response and its potential disease implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.
- Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK.
ORCID-Profile: George Kassiotis
Förderung
- Wellcome Trust
- European Research Council
- Francis Crick Institute
Zitieren
APA
Chisca, M., Larouche, J. D., Xing, Q., & Kassiotis, G. (2024). Antibodies against endogenous retroviruses. Immunological Reviews. https://doi.org/10.1111/imr.13378
Vancouver
Chisca M, Larouche JD, Xing Q, Kassiotis G. Antibodies against endogenous retroviruses. Immunological Reviews. 2024. doi:10.1111/imr.13378
BibTeX
@article{Chisca2024,
author = {Chisca, Mihaela and Larouche, Jean-David and Xing, Qi and Kassiotis, George},
title = {Antibodies against endogenous retroviruses},
journal = {Immunological Reviews},
year = {2024},
doi = {10.1111/imr.13378}
}
EUVIMED